review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1159/000342961 |
P8608 | Fatcat ID | release_izs5pkxldzc37ewe7pdilswlta |
P698 | PubMed publication ID | 23235517 |
P50 | author | Rebecca A Moss | Q57614902 |
Benjamin A Krantz | Q59936014 | ||
P2093 | author name string | Robert L Fine | |
Anthony P Gulati | |||
Dawn A Tsushima | |||
Kelley B Mowatt | |||
Stephen Schreibman | |||
Wendy N Moyal | |||
P2860 | cites work | Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system | Q28262479 |
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms | Q33373397 | ||
Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas | Q33378539 | ||
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors | Q33402226 | ||
Guidelines for diagnosis and therapy of MEN type 1 and type 2. | Q34104591 | ||
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors | Q34163515 | ||
Everolimus for advanced pancreatic neuroendocrine tumors. | Q34399809 | ||
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors | Q35001754 | ||
Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. | Q35640833 | ||
Small-cell carcinomas of the gastrointestinal tract: a review | Q35822654 | ||
Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors | Q35915022 | ||
Hepatic neuroendocrine metastases: chemo- or bland embolization? | Q35930191 | ||
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors | Q35982682 | ||
Multiple endocrine neoplasia--introduction | Q35987830 | ||
Molecular genetics of multiple endocrine neoplasia types 1 and 2. | Q36111935 | ||
First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas | Q36335402 | ||
The multiple endocrine neoplasia syndromes | Q36622153 | ||
Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin | Q36671420 | ||
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States | Q37195528 | ||
Activity of sunitinib in patients with advanced neuroendocrine tumors | Q39963579 | ||
The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1. | Q42458822 | ||
Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds* | Q42464524 | ||
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group | Q43286770 | ||
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours | Q43596241 | ||
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. | Q43754199 | ||
Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours | Q44022304 | ||
Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours | Q44856223 | ||
Resection of pancreatic neuroendocrine tumors: results of 70 cases | Q46079767 | ||
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors | Q46900223 | ||
Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors | Q46975692 | ||
Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma | Q57823664 | ||
P433 | issue | 3 | |
P921 | main subject | multiple endocrine neoplasia | Q1553018 |
P304 | page(s) | 127-134 | |
P577 | publication date | 2012-12-08 | |
P1433 | published in | Oncology | Q2016300 |
P1476 | title | Treatment of multiple endocrine neoplasia 1/2 tumors: case report and review of the literature | |
P478 | volume | 84 |